Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$46,504,000
-$3,470,600 QoQ
Shares Held
800,000
-7.0% QoQ
Ownership
0.538%
of shares outstanding
% of Portfolio
2.71%
of 13F equity value
Holder Rank
#34
of 329 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NOVO HOLDINGS A/S holds $1,241,938,796 across 18 Biotechnology names. PCVX ranks #10 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
5,350,000 | $217,370,500 | |
| 2 | COAG |
Hemab Therapeutics Holdings, Inc.
|
4,180,550 | $153,551,601 | |
| 3 | MPLT |
MapLight Therapeutics, Inc.
|
3,686,622 | $132,128,532 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,125,000 | $131,703,750 | |
| 5 | AVLN |
Avalyn Pharma Inc.
|
3,883,289 | $127,837,873 | |
| 6 | AVBP |
ArriVent BioPharma, Inc.
|
1,500,000 | $52,110,000 | |
| 7 | ELVN |
Enliven Therapeutics, Inc.
|
1,000,000 | $50,750,000 | |
| 8 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,320,000 | $49,394,400 |
All Filings in PCVX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,504,000 | 800,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $49,974,600 | 860,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $42,271,622 | 916,160 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $33,000,083 | 916,160 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $29,784,361 | 916,160 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $34,550,400 | 915,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $61,395,000 | 750,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $85,702,500 | 750,000 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $71,734,500 | 950,000 | Shares | Sole | 2024-08-20 | |
| 2024-03-31 | $57,721,950 | 845,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $53,066,000 | 845,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $43,078,100 | 845,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $42,199,300 | 845,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $27,922,600 | 745,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $34,763,750 | 725,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $19,768,920 | 823,705 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $17,923,820 | 823,705 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $8,234,505 | 416,937 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $11,078,016 | 416,937 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $32,158,971 | 651,255 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $27,876,795 | 881,898 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||